Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.

@article{Zile2008ApplicationOI,
  title={Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial.},
  author={Michael R. Zile and Robert C Bourge and Tom D Bennett and Lynne Warner Stevenson and Yong Keun Cho and Philip B. Adamson and Mark F Aaron and Juan M. Aranda and William T. Abraham and Frank W. Smart and Fred J. Kueffer},
  journal={Journal of cardiac failure},
  year={2008},
  volume={14 10},
  pages={816-23}
}
BACKGROUND Nearly half of all patients with chronic heart failure (HF) have a normal ejection fraction (EF), and abnormal diastolic function (ie, diastolic heart failure [DHF]). However, appropriate management of DHF patients remains a difficult and uncertain challenge. METHODS AND RESULTS The Chronicle Offers Management to Patients with Advanced Signs… CONTINUE READING